BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 22155828)

  • 21. Interaction of artemisinins with oxyhemoglobin Hb-FeII, Hb-FeII, carboxyHb-FeII, heme-FeII, and carboxyheme FeII: significance for mode of action and implications for therapy of cerebral malaria.
    Coghi P; Basilico N; Taramelli D; Chan WC; Haynes RK; Monti D
    ChemMedChem; 2009 Dec; 4(12):2045-53. PubMed ID: 19844934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate.
    de Souza JB; Okomo U; Alexander ND; Aziz N; Owens BM; Kaur H; Jasseh M; Muangnoicharoen S; Sumariwalla PF; Warhurst DC; Ward SA; Conway DJ; Ulloa L; Tracey KJ; Foxwell BM; Kaye PM; Walther M
    PLoS One; 2010 Apr; 5(4):e9867. PubMed ID: 20419161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria.
    Francischetti IM; Oliveira CJ; Ostera GR; Yager SB; Debierre-Grockiego F; Carregaro V; Jaramillo-Gutierrez G; Hume JC; Jiang L; Moretz SE; Lin CK; Ribeiro JM; Long CA; Vickers BK; Schwarz RT; Seydel KB; Iacobelli M; Ackerman HC; Srinivasan P; Gomes RB; Wang X; Monteiro RQ; Kotsyfakis M; Sá-Nunes A; Waisberg M
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):786-98. PubMed ID: 22116094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple quinoline salt derivative is active in vitro against Plasmodiumfalciparum asexual blood stages and inhibits the development of cerebral malaria in murine model.
    Bezerra Bellei JC; Glanzmann N; Carpinter BA; Renhe DC; Marques CB; Azevedo MR; Barreto LM; Rocha VN; Karine da Costa Nunes I; Gualberto Pereira HM; Coimbra ES; Ferraz Coelho EA; David da Silva A; de Pilla Varotti F; Gorza Scopel KK
    Chem Biol Interact; 2022 Mar; 355():109848. PubMed ID: 35149084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S1P is associated with protection in human and experimental cerebral malaria.
    Finney CA; Hawkes CA; Kain DC; Dhabangi A; Musoke C; Cserti-Gazdewich C; Oravecz T; Liles WC; Kain KC
    Mol Med; 2011; 17(7-8):717-25. PubMed ID: 21556483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiplasmodial profile of selected compounds from Malaria Box: in vitro evaluation, speed of action and drug combination studies.
    de Souza GE; Bueno RV; de Souza JO; Zanini CL; Cruz FC; Oliva G; Guido RVC; Aguiar ACC
    Malar J; 2019 Dec; 18(1):447. PubMed ID: 31888654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Slow and continuous delivery of a low dose of nimodipine improves survival and electrocardiogram parameters in rescue therapy of mice with experimental cerebral malaria.
    Martins YC; Clemmer L; Orjuela-Sánchez P; Zanini GM; Ong PK; Frangos JA; Carvalho LJ
    Malar J; 2013 Apr; 12():138. PubMed ID: 23617605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Heme Oxygenase 1 with Lung Protection in Malaria-Associated ALI/ARDS.
    Pereira ML; Ortolan LS; Sercundes MK; Debone D; Murillo O; Lima FA; Marinho CR; Epiphanio S
    Mediators Inflamm; 2016; 2016():4158698. PubMed ID: 27974865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of artesunate combined with Atractylodes lancea or Prabchompoothaweep remedy extracts as adjunctive therapy for the treatment of cerebral malaria.
    Plirat W; Chaniad P; Phuwajaroanpong A; Konyanee A; Viriyavejakul P; Septama AW; Punsawad C
    BMC Complement Med Ther; 2023 Sep; 23(1):332. PubMed ID: 37730604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artesunate-erythropoietin combination for murine cerebral malaria treatment.
    Bienvenu AL; Ferrandiz J; Kaiser K; Latour C; Picot S
    Acta Trop; 2008 May; 106(2):104-8. PubMed ID: 18359468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria.
    Du Y; Chen G; Zhang X; Yu C; Cao Y; Cui L
    Int Immunopharmacol; 2017 Jul; 48():219-230. PubMed ID: 28531845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cysteamine broadly improves the anti-plasmodial activity of artemisinins against murine blood stage and cerebral malaria.
    Moradin N; Torre S; Gauthier S; Tam M; Hawari J; Vandercruyssen K; De Spiegeleer B; Fortin A; Stevenson MM; Gros P
    Malar J; 2016 May; 15(1):260. PubMed ID: 27150250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor (VEGF) and lovastatin suppress the inflammatory response to Plasmodium berghei infection and protect against experimental cerebral malaria.
    Canavese M; Crisanti A
    Pathog Glob Health; 2015 Sep; 109(6):266-74. PubMed ID: 26392164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of proveblue (methylene blue) in an experimental cerebral malaria murine model.
    Dormoi J; Briolant S; Desgrouas C; Pradines B
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3412-4. PubMed ID: 23612202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haem oxygenase protects against thrombocytopaenia and malaria-associated lung injury.
    de Azevedo-Quintanilha IG; Medeiros-de-Moraes IM; Ferreira AC; Reis PA; Vieira-de-Abreu A; Campbell RA; Weyrich AS; Bozza PT; Zimmerman GA; Castro-Faria-Neto HC
    Malar J; 2020 Jul; 19(1):234. PubMed ID: 32611348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin for malaria therapy.
    Reddy RC; Vatsala PG; Keshamouni VG; Padmanaban G; Rangarajan PN
    Biochem Biophys Res Commun; 2005 Jan; 326(2):472-4. PubMed ID: 15582601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localized delivery of carbon monoxide.
    Steiger C; Hermann C; Meinel L
    Eur J Pharm Biopharm; 2017 Sep; 118():3-12. PubMed ID: 27836646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimalarial efficacy of Pongamia pinnata (L) Pierre against Plasmodium falciparum (3D7 strain) and Plasmodium berghei (ANKA).
    Satish PVV; Sunita K
    BMC Complement Altern Med; 2017 Sep; 17(1):458. PubMed ID: 28893216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lambda-carrageenan treatment exacerbates the severity of cerebral malaria caused by Plasmodium berghei ANKA in BALB/c mice.
    Recuenco FC; Takano R; Chiba S; Sugi T; Takemae H; Murakoshi F; Ishiwa A; Inomata A; Horimoto T; Kobayashi Y; Horiuchi N; Kato K
    Malar J; 2014 Dec; 13():487. PubMed ID: 25495520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.
    Tyagi RK; Gleeson PJ; Arnold L; Tahar R; Prieur E; Decosterd L; Pérignon JL; Olliaro P; Druilhe P
    BMC Med; 2018 Oct; 16(1):181. PubMed ID: 30269689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.